News EN
Dear patients, relatives and interested parties, On Thursday afternoon, 28.04.2022, from 13:30, a symposium will be held at the USZ on the occasion of the 1000th liver transplant. You will…
“What is hepatitis A?” Prof. Moradpour illustrates how important hygiene measures are in the prevention of hepatitis A. An important recommendation for risk groups or world travellers: There is an effective protection by the hepatitis A vaccination!
“What is hepatitis E?” Prof. Moradpour explains the possible risks of infection, symptoms and prevention. With about 20 million infections and 70,000 deaths worldwide, the enterally transmitted virus is still very widespread.
Hepatitis A (Part 1)“How widespread is hepatitis A?” From transmission, hygiene measures, symptoms to treatment, Prof. Moradpour brings us closer to the liver disease hepatitis A, which is mostly no…
The INTERNATIONAL LIVER CANCER MOVEMENT calls for increased efforts to improve patient outcomes:
PREVENTION, EARLY DETECTION, and ACCESS TO CARE.
“I am so happy that we can do this interview for our patients” is how PD Dr. med. Benedetta Terziroli starts the engaging interview about autoimmune hepatitis. In a patient-oriented and truly educational dialogue about the complex topic of autoimmune hepatitis, she gives us a sense of empathy, commitment to patients and knowledge.
“What is autoimmune hepatitis” is the question with which PD Dr. med. Benedetta Terziroli, opens a very exciting and patient-friendly presentation on this rare chronic liver disease.
“Why the renaming of NAFLD to MAFLD?” Dr Lange takes us on the exciting journey of discovery, development and the new findings about fatty liver disease. In a sympathetic and patient-oriented way, she explains the increase and consequences of this liver disease. Appeal to all patients and important in case of early diagnosis: “Everyone can support themselves or help by making healthy lifestyle changes!”
“What is a fatty liver?” Dr Lange conscientiously draws our attention to the differences in fatty liver disease and the current findings of research. She prudently enlightens us about the causes, significance, diagnosis and treatment methods. The increasing incidence of MAFLD/NAFLD, approx. 25% of the population in Switzerland is affected, should make us all prick up our ears!
Many thanks to all companions:
Patients, relatives, specialists, sponsors, donors, members, contributors and employees.
Together we are strong!